IP Library Granted Patent US 11,383,010
Granted Patent B2
US 11,383,010 · App. 14/130,989 · Granted Jul 12, 2022

Method of dialysis for removing protein-bound toxins from the blood of patients using high-frequency electromagnetic fields

Inventors: Joachim Jankowski (Stahnsdorf, DE); Walter Zidek (Berlin, DE); Falko Brettschneider (Berlin, DE); Vera Jankowski (Stahnsdorf, DE)
Assignees: Baxter International Inc.; Baxter Healthcare SA
A61M1/14A61M1/16A61M1/1605A61M1/3681B01D61/30A61M2205/50
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,383,010
App. No.
14/130,989
Granted
Jul 12, 2022
Kind
B2
Abstract

The present invention relates to the use of a high-frequency electromagnetic field in method of dialysis where a dialyser is used for the exchange of substances, wherein the blood to be cleaned is exposed to a high-frequency electromagnetic field prior to and/or during contact with the dialyser, and to a dialysis machine for carrying out the use.

Claims (31)

1. A method of removing protein-bound toxins from the blood of a patient comprising:

providing a dialysis machine including

a dialysate flow system,

a blood flow system,

a dialyser, and

a device configured to generate a high-frequency electromagnetic field;

applying the high-frequency electromagnetic field to the blood flow system prior to and/or along the dialyser in a manner to release uraemic toxins from protein-bound states during dialysis, such that the a percentage of uraemic toxins that are released from their protein-bound states is increased versus non-application of the high-frequency electromagnetic field during dialysis; and

dialyzing the released uraemic toxins from the blood flow system into the dialysate flow system.

2. The method of claim 1 , wherein applying the high-frequency electromagnetic field in the percentage increasing manner includes applying the high-frequency electromagnetic field at a frequency of 1 MHz to 20 MHz and at an electric field strength of no more than 100 V/m.

3. The method of claim 1 , wherein applying the high-frequency electromagnetic field in the percentage increasing manner includes applying the high-frequency electromagnetic field at a frequency that is constant over time.

4. The method of claim 1 , wherein applying the high-frequency electromagnetic field in the percentage increasing manner includes applying the high-frequency electromagnetic field at a frequency that varies in a regular or irregular manner.

5. The method of claim 1 , wherein applying the high-frequency electromagnetic field in the percentage increasing manner includes applying the high-frequency electromagnetic field to blood in the blood flow system prior to and/or along the dialyser for at least a second.

6. The method of claim 1 , wherein applying the high-frequency electromagnetic field in the percentage increasing manner includes applying the high-frequency electromagnetic field having an electric field strength from 0.1 to 10 V/m.

7. The method of claim 1 , wherein applying the high-frequency electromagnetic field in the percentage increasing manner includes the high-frequency electromagnetic field having an electric field density of ≤100 mT.

8. The method of claim 1 , wherein dialyzing the released uraemic toxins from the blood flow system into the dialysate flow system includes circulating blood through the blood flow system, while circulating dialysate through the dialysate flow system, and wherein the dialyzing occurs while applying the high-frequency electromagnetic field to the blood flow system.

9. The method of claim 8 , which includes circulating blood through the blood flow system and dialysate through the dialysate flow system in opposite directions.

10. The method of claim 1 , wherein dialyzing the released uraemic toxins from the blood flow system into the dialysate flow system includes passing the released uraemic toxins across at least one semipermeable membrane of the dialyser.

11. A method for treating a patient experiencing renal failure, the method comprising:

providing a dialyser configured to receive blood from the patient and dialysate on opposite sides of a semipermeable membrane;

generating a high-frequency electromagnetic field via a high-frequency coil, a high-frequency electrode or a high-frequency capacitor;

applying the high-frequency electromagnetic field to the blood in a manner so as to break bonds between uraemic toxins and plasma proteins, causing the uraemic toxins to be freed from the plasma proteins; and

removing the freed uraemic toxins from the blood, through the semipermeable membrane and into the dialysate while flowing blood and dialysate through the dialyser.

12. The method of claim 11 , wherein generating the high-frequency electromagnetic field includes generating the high-frequency electromagnetic field at a frequency of 1 MHz to 20 MHz and at an electric field strength of no more than 100 V/m.

13. The method of claim 11 , wherein generating the high-frequency electromagnetic field includes generating the high-frequency electromagnetic field at a frequency that is constant over time.

14. The method of claim 11 , wherein generating the high-frequency electromagnetic field includes generating the high-frequency electromagnetic field at a frequency that varies in a regular or irregular manner.

15. The method of claim 11 , wherein generating the high-frequency electromagnetic field includes the high-frequency electromagnetic field having an electric field strength from 0.1 to 10 V/m.

16. The method of claim 11 , wherein generating the high-frequency electromagnetic field includes generating the high-frequency electromagnetic field having an electric field density of ≤100 mT.

17. The method of claim 11 , wherein applying the high-frequency electromagnetic field in the bond breaking manner includes applying the high-frequency electromagnetic field to blood in the blood flow system for at least a second.

18. The method of claim 11 , wherein applying the high-frequency electromagnetic field in the bond breaking manner includes applying the high-frequency electromagnetic field prior to and/or along the dialyser.

19. The method of claim 1 , wherein removing the freed uraemic toxins from the blood includes flowing blood and dialysate through the dialyser in opposite directions, while applying the high-frequency electromagnetic field to the blood.

20. The method of claim 19 , wherein removing the freed uraemic toxins from the blood includes collecting dialysate containing the freed uraemic toxins in a container.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 31, 2025
From: BAXTER INTERNATIONAL INC.
To: VANTIVE US HEALTHCARE LLC
Reel/Frame 073434/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 31, 2025
From: BAXTER HEALTHCARE SA
To: VANTIVE HEALTH GMBH
Reel/Frame 074042/0359 →
SECURITY INTEREST Recorded Jan 31, 2025
From: VANTIVE US HEALTHCARE LLC; GAMBRO RENAL PRODUCTS, INC.
To: ARES CAPITAL CORPORATION
Reel/Frame 070076/0701 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 18, 2017
From: JANKOWSKI, VERA
To: CHARITE - UNIVERSITATSMEDIZN BERLIN
Reel/Frame 043334/0606 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 18, 2015
From: CHARITÉ - UNIVERSITAETSMEDIZN BERLIN
To: BAXTER INTERNATIONAL INC.; BAXTER HEALTHCARE SA
Reel/Frame 035859/0191 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 28, 2014
From: JANKOWSKI, JOACHIM; ZIDEK, WALTER; BRETTSCHNEIDER, FALKO
To: CHARITÉ - UNIVERSITÄTSMEDIZN BERLIN
Reel/Frame 032058/0657 →